Status:
COMPLETED
MR Fingerprinting: A Novel Sequence Applied to Neuroimaging
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Disease;Neurological
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Magnetic Resonance Imaging (MRI) has become one of most important medical imaging tools over the past 30 years because it is non-invasive, requires no ionizing radiation, and provides exquisite images...
Detailed Description
The purpose of this study is to evaluate novel quantitative MRI techniques in clinical studies to determine whether they can provide better, faster and more useful information for clinical diagnosis. ...
Eligibility Criteria
Inclusion
- The study will include English-speaking patients that are already scheduled to undergo a clinical neurological MRI for diagnostic purposes.
Exclusion
- Pregnant women will be excluded.
Key Trial Info
Start Date :
March 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT03800537
Start Date
March 8 2019
End Date
August 18 2022
Last Update
June 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599